LB Pharmaceuticals
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Penn Plz Ste 1025, New York, New York,...Phone Number
(212) 605-0300Website
www.lbpharma.usRevenue
-Stock Symbol
LBRXIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About LB Pharmaceuticals
LB Pharmaceuticals is a development stage life sciences company devoted to commercializing novel and improved versions of successful CNS treatments used extensively overseas but never developed, approved, or marketed in the United States. The company is based in New York, NY.Explore more
LB Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is LB Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if LB Pharmaceuticals is spiking on competitors!
Funding: Get notified immidiatlly once LB Pharmaceuticals has new funding data
Product Launch: Get notified when LB Pharmaceuticals launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if LB Pharmaceuticals had a recent Job posting/layoffs
Earning: See what the market has to say on LB Pharmaceuticals recently announced quarterly report
LB Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at LB Pharmaceuticals
Check if LB Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at LB Pharmaceuticals
Find more new buyers
Compare Similar Companies to LB Pharmaceuticals
Compare insights from companies similar to LB Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
LB Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
LB Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about LB Pharmaceuticals.
LB Pharmaceuticals financials insights
Gather financial insights about LB Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series B
$10M
2024
Series C
$75M
2025
IPO
$285M
LB Pharmaceuticals Tech Stack
A closer look at the technologies used by LB Pharmaceuticals
See more technologies
Most Recent Scoops
Open Position
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Pharmaceuticals, Clinical Operations
Person-Based
Pharmaceuticals, Clinical Operations
LB Pharmaceuticals News & Media
LB Pharmaceuticals Appoints Susan G. Kozauer, M.D. as Chief Medical Officer
NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that address the multiple dimensions of underserved brain disorders, today announced the appointment of Susan G. Kozauer, M.D. as Chief Medical Officer.LB Pharmaceuticals Appoints Joseph Miller as Chief Financial Officer
NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that address the multiple dimensions of underserved brain disorders, today announced the appointment of Joseph Miller as Chief Financial Officer.LB Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Announced accelerated timing of topline data readout from the pivotal Phase 3 NOVA-2 trial of LB-102 in schizophrenia in the first half of 2027LB Pharmaceuticals Announces $150 Million Private Placement
NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that address the multiple dimensions of underserved brain diseases, today announced that it has entered into a securities purchase agreement to sell 3,577,560 shares of its common stock and pre-funded warrants to purchase up to 715,513 shares of its common stock to a limited group of i
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding LB Pharmaceuticals
Sign Up For FreeTo access detailed company insights
LB Pharmaceuticals is a development stage life sciences company devoted to commercializing novel and improved versions of successful CNS treatments used extensively overseas but never developed, approved, or marketed in the United States. The company is based in New York, NY.... Read More
